Vimarsana
Biggest News Aggregation in the World

Page 5 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush - Vimarsana News

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […]

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update - Vimarsana News

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

With 50% stake, Immunic, Inc. (NASDAQ:IMUX) seems to have captured institutional investors' interest - Vimarsana News

With 50% stake, Immunic, Inc. (NASDAQ:IMUX) seems to have captured institutional investors' interest

Key Insights Institutions' substantial holdings in Immunic implies that they have significant influence over the...

Source: yahoo.com
Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 6.9% in June - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 6.9% in June

Immunic, Inc. (NASDAQ:IMUX – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 2,170,000 shares, a growth of 6.9% from the June 15th total of 2,030,000 shares. Based on an average daily volume of 1,040,000 shares, the […]

Source: wkrb13.com
Immunic to Participate in Scientific and Investor Conferences in July - Vimarsana News

Immunic to Participate in Scientific and Investor Conferences in July

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...